Table 1. Mouse strains/models used for MAC infection.
Mouse strain | M. avium route of infection and dose | Productive infection (organ) | Compound screening | Reference |
---|---|---|---|---|
C57BL/6 | aerosolization; approximately 105/mouse | lung and spleen | CLR | [100] |
C57BL/6 (modified Cornell-like model) | M. avium complex strains; aerosolization (500–104 CFU/ mouse) | lung | CLR-RIF | [103] |
C57BL/6 | M. avium subsp. hominissuis; intranasal 2.25 × 107 CFU/mouse | lung | LAI | [150] |
C57BL/10 | intranasal; 105 CFU/mouse | lung, spleen, and liver | N/A | [101] |
129Sv | IV; 106 CFU/mouse | lung, spleen, and liver | N/A | [96] |
BALB/c | aerosolization; approximately 105 CFU/mouse | lung and spleen | CLR, CLR-EMB-RIF, MXF-EMB-RIF, CLR-MXF-EMB-RIF | [100] |
iNOS-/- | IV; 106 CFU/mouse | liver | N/A | [151] |
iNOS-/- | IV; 106 CFU/mouse | lung, spleen, and liver | N/A | [96] |
TNFα p55 receptor-/- | IV; 106 CFU/mouse | lung and spleen | N/A | [152] |
Beige | aerosolization; approximately 105 CFU/mouse | lung and spleen | CLR | [100] |
Beige | IV; 106 CFU/mouse | lung, spleen, liver, and gut | N/A | [90] |
Nude | aerosolization; approximately 105 CFU/mouse | lung and spleen | CLR, CLR-EMB-RIF, MXF-EMB-RIF, CLR-MXF-EMB-RIF | [100] |
Abbreviations: CFU, colony-forming units; CLR, clarithromycin; EMB, ethambutol; iNOS, inducible NO synthase; IV, intravenous; LAI, liposomal amikacin for inhalation; MXF, moxifloxacin; N/A, not applicable; NO, nitric oxide; RIF, rifampin; TNF, tumor necrosis factor.